PDF-versjon opprettes. Dette kan ta litt tid.
English pages (EN) Sámegiel skovi (SA)

Maintaining patient safety with new surgical and invasive methods

13 References

Publisert 8. februar 2022

ISBN 978-82-8465-022-7

  1. Dahl OT, Kjell Magne. Historikk for Norsk Gastrointestinal Cancer Gruppe (NGICG) (History of the Norwegian Gastro Intestinal Cancer Group) Onkonytt. 2019(1):73-5.
  2. Cancer Registry of Norway. Årsrapport for tykk- og endetarmskreft 2020. 2021. (Annual report on colorectal cancer).
  3. Norwegian Directorate of Health. National Action Programme with Guidelines for Diagnostics, Treatment and Follow-up of Colorectal Cancer. 8th edition. 2020.
  4. Larsen IK, Møller B, Johannesen T, Robsahm TE, Grimsrud TK, Larønningen S, et al. Cancer in Norway 2018: Cancer incidence, mortality, survival and prevalence in Norway. 2019.
  5. Havenga K, Grossmann I, DeRuiter M, Wiggers T. Definition of total mesorectal excision, including the perineal phase: technical considerations. Dig Dis. 2007;25(1):44-50.
  6. Wasmuth HH, Faerden AE, Myklebust TA, Pfeffer F, Norderval S, Riis R, et al. Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg. 2020;107(1):121-30.
  7. Wasmuth HA. Hvordan forstå et kirurgisk tilbakeslag? TaTME-saken i Norge (How to understand a surgical recurrence? The taTME case in Norway). Kirurgen 2020. 2020.
  8. Cancer Registry of Norway. Årsrapport for tykk- og endetarmskreft 2019. 2020 (Annual report on colorectal cancer).
  9. Steigen S. Patologisk vurdering ved rektumcancer. Patologisk vurdering ved rektumcancer (Pathological assessment of rectal cancer). 2014.
  10. Wibe AE, Birger Henning. Kirurgisk behandling av endetarmskreft (Surgical treatment of rectal cancer). Tidsskrift for Den norske lægeforening (Journal of the Norwegian Medical Association). 2007.
  11. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet (London, England). 1986;1(8496):1479-82.
  12. Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010;24(5):1205-10.
  13. Veltcamp Helbach M, Deijen CL, Velthuis S, Bonjer HJ, Tuynman JB, Sietses C. Transanal total mesorectal excision for rectal carcinoma: short-term outcomes and experience after 80 cases. Surg Endosc. 2016;30(2):464-70.
  14. Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC cancer. 2016;16:380.
  15. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al. Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Ann Surg. 2017;266(1):111-7.
  16. Xu W, Xu Z, Cheng H, Ying J, Cheng F, Xu W, et al. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis. Eur J Surg Oncol. 2016;42(12):1841-50.
  17. Hafstad A. Granskning: Ny metode ga flere tilbakefall (Review: New method gave more recurrences) Dagens medisin, 2019.
  18. Warren OJ, Solomon MJ. The Drive Toward Transanal Total Mesorectal Excision – Science or Rhetoric? Dis Colon Rectum. 2015;58(9):909-10.
  19. Fearnhead NS, Acheson AG, Brown SR, Hancock L, Harikrishnan A, Kelly SB, et al. The ACPGBI recommends pause for reflection on transanal total mesorectal excision. Colorectal Dis. 2020;22(7):745-8.
  20. Atallah S, Sylla P, Wexner SD. Norway versus The Netherlands: will taTME stand the test of time? Tech Coloproctol. 2019;23(9):803-6.
  21. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg. 1982;69(10):613-6.
  22. Wibe AS, E; Bjerkeset, T; Carlsen, E; Langmark, F; Norstein, J; Wiig, J. N.; Søreide, O, pa vegne av Norsk Rectum Cancer Gruppe. Rectumcancerregisteret gir kvalitetsforbedring i kreftbehandlingen (Rectal cancer registry improves the quality of cancer treatment). The Norwegian Journal of Epidemiology 2001.
  23. Norwegian Directorate of Health. National Action Programme with Guidelines for Diagnostics, Treatment and Follow-up of Colorectal Cancer, 20 June 2017, 5th edition (2017).
  24. Gachabayov M, Bergamaschi R. Is taTME delivering? Updates Surg. 2019;71(1):13-5.
  25. Hafstad A. Bent Høie (H) vil vite hva som har skjedd (Bent Høie (H) wants to know what happened). Dagens medisin, 2019.
  26. Norwegian Directorate of Health. National Action Programme with Guidelines for Diagnostics, Treatment and Follow-up of Colorectal Cancer, 10 April 2019, 6th edition. 2019.
  27. Hafstad A. Høie pålegger RHF-ene å sende ut bedre pasientinformasjon (Høie requires RHA to issue better patient information). Dagens Medisin. 2019.
  28. Larsen SG, Pfeffer F, Korner H. Norwegian moratorium on transanal total mesorectal excision. Br J Surg. 2019;106(9):1120-1.
  29. Coloproctology ESo. ESCP’s 14th Scientific and Annual Meeting 2019. Available from: https://www.escp.eu.com/conference-and-events/past-conferences/escp-vienna-2019
  30. Norwegian Directorate of Health. National Action Programme with Guidelines for Diagnostics, Treatment and Follow-up of Colorectal Cancer, 11 September.2019, 7th edition. 2019.
  31. The National System for Managed Introduction of New Health Technologies (New Methods). Transanal total mesorectal excision (TaTME). 2020.
  32. Norwegian Ministry of Health and Care Services. Report to the Storting no. 10 (2012-2013) Good Quality – Safe Services – Quality and Patient Safety in the Health and Care Service, (2012).
  33. Norwegian Directorate of Health. National guide: Trialling treatment – national principles 2019. Available from: https://www.helsedirektoratet.no/veiledere/utprovende-behandling
  34. Bjerkeset T, Edna TH. Rectal cancer: the influence of type of operation on local recurrence and survival. Eur J Surg. 1996;162(8):643-8.
  35. National Institute for Health Care and Excellence (NICE). Transanal total mesorectal excision of the rectum. Interventional procedures guidance [IPG514]. 2015 27.03.2015.
  36. TaTME International. International taTME educational collaborative. Available from: https://www.tatme.surgery/?page_id=460
  37. Metoder N. Bestillerforum RHF – Arsoppsummering 2020. 2021 05.02.2021. (New Methods Ordering Forum RHA - Annual summaries).
  38. Kørner H. New health technologies--from development to everyday practice. Journal of the Norwegian Norwegian Medical Association. 2003;123(3):340-3.
  39. Black N. Why we need observational studies to evaluate the effectiveness of health care. Bmj. 1996;312(7040):1215-8.
  40. Hariton E, Locascio JJ. Randomised controlled trials – the gold standard for effectiveness research: Study design: randomised controlled trials. Bjog. 2018;125(13):1716.
  41. Nyberg K, Hedman P. Swedish guidelines for registry-based randomized clinical trials. Ups J Med Sci. 2019;124(1):33-6.
  42. Norwegian Ministry of Health and Care Services. National Clinical Trial Action Plan. 2021.
  43. International expert consensus guidance on indications, implementation and quality measures for transanal total mesorectal excision. Colorectal Dis. 2020;22(7):749-55.
  44. Fure B, Ormstad SS, Vang VJ, Lauvrak V, Frønsdal KB, Skår Å, et al. Mini-method assessment: Rask og trygg innføring av nye metoder i sykehus (Rapid and safe introduction of new methods in hospitals). The Norwegian Journal of Epidemiology. 2013;23(2).
  45. Norwegian Institute of Public Health. Den nasjonale databasen for mini-metodevurdering 2020 (The national database for mini-method assessment). Available from: https://www.helsebiblioteket.no/minimetodevurdering
  46. Norwegian Institute of Public Health. Den nasjonale databasen for mini-metodevurdering (The national database for mini-method assessment). Available from: https://www.helsebiblioteket.no/minimetodevurdering/sok
  47. Oslo University Hospital. Intervention Centre: Oslo University Hospital; 2021. Available from: https://oslo-universitetssykehus.no/avdelinger/teknologi-og-innovasjonsklinikken/intervensjonssenteret
  48. Nasjonalt Servicemiljø For Medisinske Kvalitetsregistre (National Service Community for Medical Quality Registries). Norwegian National Registry for Gastrointestinal Surgery (NoRGast) 2021. Available from: https://www.kvalitetsregistre.no/register/mage-og-tarm/norsk-register-gastrokirurgi-norgast
  49. Nasjonalt Servicemiljø For Medisinske Kvalitetsregistre (National Service Community for Medical Quality Registries). Om medisinske kvalitetsregistre 2021 (About medical quality registries). Available from: https://www.kvalitetsregistre.no/om-medisinske-kvalitetsregistre
  50. Guren MG, Kørner H, Pfeffer F, Myklebust T, Eriksen MT, Edna TH, et al. Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. Acta Oncol. 2015;54(10):1714-22.
  51. Gaard M, Vonen B, Tveit KM, Hoff G, Carlsen E. Eget register for kolorektal kreft (Separate colorectal cancer registry). Journal of the Norwegian Medical Association. 2007(21):127: 2834-5.
  52. Wibe A, Svensson E, Bjerkeset T, Carlsen E, Langmark F, Norstein J, et al. Rectumcancerregisteret gir kvalitetsforbedring i kreftbehandlingen (Rectal cancer registry improves the quality of cancer treatment). The Norwegian Journal of Epidemiology. 2009;11(2).
  53. Norwegian Ministry of Health and Care Services. Forskrift om ledelse og kvalitetsforbedring i helse- og omsorgstjenesten (The Norwegian Regulations for Management and Quality Improvement in the Health and Social Care Services) 2016. Available from: https://lovdata.no/dokument/LTI/forskrift/2016-10-28-1250
  54. Norwegian Ministry of Health and Care Services. Lov om pasient- og brukerrettigheter (pasient- og brukerrettighetsloven) (Act relating to patient and user rights (the Norwegian Patient and User Rights Act)), Lovdata. Available from: https://lovdata.no/dokument/NL/lov/1999-07-02-63?qpasient%20og%20brukerrettighetsloven
  55. Norwegian Ministry of Health and Care Services. Lov om medisinsk og helsefaglig forskning (helseforskningsloven) (Medical and Health Research Act (Norwegian Health Research Act)): 2008. Available from: https://lovdata.no/dokument/NL/lov/2008-06-20-44
  56. Norwegian Ministry of Health and Care Services. Forskrift om pasientjournal (pasientjournalforskriften) (Patient Record Regulations (Patient Records Regulations)), 2019. Available from: https://lovdata.no/dokument/SF/forskrift/2019-03-01-168
  57. Norwegian Ministry of Health and Care Services. Lov om helsepersonell m.v. (helsepersonelloven) (Act relating to healthcare professionals, etc. (the Norwegian Healthcare Professionals Act)), 1999. Available from: https://lovdata.no/dokument/NL/lov/1999-07-02-64
  58. Norwegian Centre for Research Data. Kvalitetssikring i helsesektoren 2021 (Quality assurance in the health sector 2021). Available from: https://www.nsd.no/personverntjenester/oppslagsverk-for-personvern-i-forskning/kvalitetssikring-i-helsesektoren
  59. Norwegian Ministry of Health and Care Services. Report to the Storting no. 7 (2019-2020). National Health and Hospital Plan 2020-2023. 2019.
  60. Norwegian System of Patient Injury Compensation (NPE). Available from: https://www.npe.no/no/Om-NPE/
  61. The National System for Managed Introduction of New Health Technologies (New Methods). Available from: https://nyemetoder.no
  62. Proba. Evaluation of the system of New Methods in the specialist health service. 2021.
  63. Busund R. TAVI – fra utprøvende behandling til rutineinngrep (TAVI – from trial treatment to routine intervention). Kirurgen. 2016.
  64. Norwegian Directorate of Health. Cases considered by the Prioritisation Board 2007-2017. Available from: https://www.helsedirektoratet.no/tema/prioritering-i-helsetjenesten/saker-behandlet-av-prioriteringsradet-2007-
  65. Nasjonalt Kunnskapssenter for Helsetjenesten (National Knowledge Centre for the Health Service). Kateterbasert implantasjon av aortaklaffer (Catheter-based implantation of aortic valves). 2008.
  66. Øian PG, Emma; Iversen, Ole-Erik; Grammeltvedt, Gorm A. Etablering av behandlingsmetoder uten kritisk refleksjon (Establishment of treatment methods without critical reflection). Journal of the Norwegian Medical Association. 2021.
  67. Storvik AG. Slår alarm om bivirkninger hos norske kvinner etter steriliseringsmetode (Alarm raised about adverse effects experienced by Norwegian women due to sterilisation method). Dagens Medisin. 2020.
     

Fortsett å lese:Appendices to the report

Last ned / skriv ut:

Bla i rapporten:

Bla i rapporten: